韓国政府「å€å¯‡ã®ç•¥å¥ªã€ç«‹è¨¼ä¸è¶³ã€ã€€å¯¾é¦¬ã®ç›—難ä»åƒè¨´è¨Ÿï¼šæœæ—¥æ–°èžãƒ‡ã‚¸ã‚¿ãƒ«é•·å´ŽçœŒå¯¾é¦¬å¸‚ã®è¦³éŸ³å¯ºã‹ã‚‰ç›—ã¾ã‚Œã€éŸ“国ã§è¦‹ã¤ã‹ã£ãŸä»åƒã‚’ã‚ãる訴訟ã§ï¼—æ—¥ã€éŸ“国ã®æµ®çŸ³å¯ºï¼ˆãƒ—ソクサ）ãŒã€Œå€å¯‡ï¼ˆã‚ã“ã†ï¼‰ã«ç•¥å¥ªã•ã‚ŒãŸã€ãªã©ã¨ä¸»å¼µã—ã¦ã„ã‚‹ã“ã¨ã«ã¤ã„ã¦ã€éŸ“国政府å´ã¯ã€Œå…·ä½“çš„ã«ç«‹è¨¼ã§ãã¦ã„ãªã„ã€ã¨æŒ‡æ‘˜ã—ãŸã€‚ä¿ç®¡ä¸ã®ä»åƒã«ã¤ã„ã¦ã€ŒçœŸã®æ‰€æœ‰è€…ã«æ¸¡ã•ãªã‘ã‚Œã°ãªã‚‰ãªã„ã€ã¨è¡¨æ˜Žã€‚ãŸã 観音寺ã«è¿”é‚„ã™ã‚‹ã¨ã®è€ƒãˆã¯ç¤ºã•ãªã‹ã£ãŸã€‚ å•é¡Œã«ãªã£ã¦ã„ã‚‹ã®ã¯ã€é•·å´ŽçœŒæŒ‡å®šæœ‰å½¢æ–‡åŒ–財「観世音è©è–©ï¼ˆã¼ã•ã¤ï¼‰ååƒï¼ˆã–ãžã†ï¼‰ã€ã€‚ï¼’ï¼ï¼‘ï¼’å¹´ã«è¦³éŸ³å¯ºã‹ã‚‰ç›—ã¾ã‚Œã€éŸ“国ã§çªƒç›—団ãŒæ‘˜ç™ºã•ã‚ŒãŸéš›ã«ã€æŠ¼åŽã•ã‚ŒãŸã€‚観音寺や日本政府ã¯è¿”還を求ã‚ã¦ã„ãŸãŒã€æµ®çŸ³å¯ºãŒæ‰€æœ‰æ¨©ã‚’主張ã—ã€ä¿ç®¡ã—ã¦ã„る韓国政府ã«å¼•ã渡ã—を求ã‚ã¦æ訴。７日ã¯å¤§ç”°ï¼ˆãƒ†ã‚¸ãƒ§ãƒ³ï¼‰åœ°è£ã§å£é å¼è«–ã®æº–備手続ããŒè¡Œã‚ã‚ŒãŸã€‚ 浮石寺å´ã¯ä»Šå¾Œã€è¨´è¨Ÿã®ä¸ã§ç•¥å¥ªã•ã‚ŒãŸçµŒç·¯ãªã©ã«ã¤ã„ã¦ç«‹è¨¼ã—ã¦ã„ã考ãˆã‚’示ã—ãŸã€‚（大田ï¼æ±å²¡å¾¹ï¼‰
3分ã®2è°å¸ã®éµã‚’æ¡ã‚‹å€™è£œè€…ï¼‘ï¼—äººï¼ | SEALDs POST
『モトケン on Twitter: "与党å´ãŒï¼“分ã®ï¼’ã‚’å–ã‚‹ã¨ã€ã™ãã«ã§ã‚‚憲法ãŒæ”¹æ£ã•ã‚Œã¦æˆ¦äº‰ã‚’ãŠã£ã±ã˜ã‚ã‚‹ã ã‚ã†ã€ã¨è¨€ã‚ã‚“ãŒã”ã¨ãã®ãƒ„イートãŒæµã‚Œã¦ãã‚‹ã®ã ãŒã€ãã†ã„ã†ã®ã¯ã€é‡Žå…šã®ã‚ªã‚ªã‚«ãƒŸå°‘年化ã¨è¨€ã£ã¦ã„ã„ã‚“ã˜ã‚ƒãªã„ã‹ãªã€‚秘密ä¿è·æ³•ã®ã¨ãも秘密ä¿è·æ³•ãŒæˆç«‹ã™ã‚Œã°æ—¥æœ¬ã¯æš—黒社会ã«ãªã‚‹ã¨è¨€ã£ã¦ãŸã‘ã©ã€ãã†ãªã£ã¦ãªã„ã—。"ã€ã¸ã®ã‚³ãƒ¡ãƒ³ãƒˆ
モトケン on Twitter: "与党å´ãŒï¼“分ã®ï¼’ã‚’å–ã‚‹ã¨ã€ã™ãã«ã§ã‚‚憲法ãŒæ”¹æ£ã•ã‚Œã¦æˆ¦äº‰ã‚’ãŠã£ã±ã˜ã‚ã‚‹ã ã‚ã†ã€ã¨è¨€ã‚ã‚“ãŒã”ã¨ãã®ãƒ„イートãŒæµã‚Œã¦ãã‚‹ã®ã ãŒã€ãã†ã„ã†ã®ã¯ã€é‡Žå…šã®ã‚ªã‚ªã‚«ãƒŸå°‘年化ã¨è¨€ã£ã¦ã„ã„ã‚“ã˜ã‚ƒãªã„ã‹ãªã€‚秘密ä¿è·æ³•ã®ã¨ãも秘密ä¿è·æ³•ãŒæˆç«‹ã™ã‚Œã°æ—¥æœ¬ã¯æš—黒社会ã«ãªã‚‹ã¨è¨€ã£ã¦ãŸã‘ã©ã€ãã†ãªã£ã¦ãªã„ã—。"
『早ã‘ã‚Œã°å¹´å†…ã«å›½æ°‘投票ã‹ãª - 誰ã‹ã®å¦„想・ã¯ã¦ãªãƒ–ãƒã‚°ç‰ˆã€ã¸ã®ã‚³ãƒ¡ãƒ³ãƒˆ
「リノベã€ã§å¾©æ´»ã™ã‚‹å°æ¹¾ã®æ—¥æœ¬ç¥žç¤¾â€•â€•æ´å²ã®ãªã‹ã®ã€Œè‡ªåˆ†æŽ¢ã—ã€ãŒèƒŒæ™¯ã« - Yahoo!ニュース
『「リノベã€ã§å¾©æ´»ã™ã‚‹å°æ¹¾ã®æ—¥æœ¬ç¥žç¤¾â€•â€•æ´å²ã®ãªã‹ã®ã€Œè‡ªåˆ†æŽ¢ã—ã€ãŒèƒŒæ™¯ã« - Yahoo!ニュースã€ã¸ã®ã‚³ãƒ¡ãƒ³ãƒˆ
『『『今回ã®å‚院é¸ã§è‡ªæ°‘å…šã«æŠ•ç¥¨ã™ã‚‹ã‚ˆã†ãªæœ‰æ¨©è€…ãŒå›½æ°‘投票ã§ã¯å対票をã‚ã–ã‚ã–投票ã™ã‚‹ã¨ã‚‚æ€ãˆãªã„ã‚“ã よã - 誰ã‹ã®å¦„想・ã¯ã¦ãªãƒ–ãƒã‚°ç‰ˆã€ã¸ã®ã‚³ãƒ¡ãƒ³ãƒˆã€ã¸ã®ã‚³ãƒ¡ãƒ³ãƒˆã€ã¸ã®ã‚³ãƒ¡ãƒ³ãƒˆ
『『[B! 憲法] 今回ã®å‚院é¸ã§è‡ªæ°‘å…šã«æŠ•ç¥¨ã™ã‚‹ã‚ˆã†ãªæœ‰æ¨©è€…ãŒå›½æ°‘投票ã§ã¯å対票をã‚ã–ã‚ã–投票ã™ã‚‹ã¨ã‚‚æ€ãˆãªã„ã‚“ã よã - 誰ã‹ã®å¦„想・ã¯ã¦ãªãƒ–ãƒã‚°ç‰ˆã€ã¸ã®ã‚³ãƒ¡ãƒ³ãƒˆã€ã¸ã®ã‚³ãƒ¡ãƒ³ãƒˆ
『『今回ã®å‚院é¸ã§è‡ªæ°‘å…šã«æŠ•ç¥¨ã™ã‚‹ã‚ˆã†ãªæœ‰æ¨©è€…ãŒå›½æ°‘投票ã§ã¯å対票をã‚ã–ã‚ã–投票ã™ã‚‹ã¨ã‚‚æ€ãˆãªã„ã‚“ã よã - 誰ã‹ã®å¦„想・ã¯ã¦ãªãƒ–ãƒã‚°ç‰ˆã€ã¸ã®ã‚³ãƒ¡ãƒ³ãƒˆã€ã¸ã®ã‚³ãƒ¡ãƒ³ãƒˆ
ã¼ãã¯æ°‘進党ã«å…¥ã‚Œã‚‹ï¼ˆæ±æµ©ç´€ï¼‰ï½œãƒãƒªã‚¿ã‚¹ å‚院é¸ãƒ»éƒ½çŸ¥äº‹é¸ 2016――何ã®ãŸã‚ã«æŠ•ç¥¨ã™ã‚‹ã®ã‹
『『アベ政治を許ã•ãªã„ã€ã‚·ãƒ¼ãƒ«ã‚’å‹æ‰‹ã«å‰¥ãŒã—ã¦ã¿ãŸã€‚ã€ã¸ã®ã‚³ãƒ¡ãƒ³ãƒˆ
長文日記
『長文日記ã€ã¸ã®ã‚³ãƒ¡ãƒ³ãƒˆ
『『長文日記ã€ã¸ã®ã‚³ãƒ¡ãƒ³ãƒˆã€ã¸ã®ã‚³ãƒ¡ãƒ³ãƒˆ
『アベ政治を許ã•ãªã„ã€ã‚·ãƒ¼ãƒ«ã‚’å‹æ‰‹ã«å‰¥ãŒã—ã¦ã¿ãŸã€‚
æ˜ ç”»ç›£ç£æ£®é”也ã•ã‚“ã€æ–°æœ‰æ¨©è€…ã®è‹¥è€…ã¸ãƒ¡ãƒƒã‚»ãƒ¼ã‚¸ã€Œæ£„権ã—ã¦ã„ã„。ã¸ãŸã«æŠ•ç¥¨ã—ãªã„ã§ãã‚Œã€ã€€ãƒ„イッター民åå¿œã¾ã¨ã‚
Poxel Announces Patient Enrollment Completed for Imeglimin Phase 2b Clinical Trial in Type 2 Diabetes in Japan
Takeda to Partner with Altos Therapeutics to Develop Promising Compound for the Treatment of Gastroparesis
Recent Settlement in Promega/Genovis Case Maintains Continued Offering of Promega IdeS/IdeZ Proteases
Takeda Receives European Commission Approval of ADCETRIS® (brentuximab vedotin) for Consolidation Treatment in Post-Transplant Hodgkin Lymphoma
Cardiovascular Systems Submits Diamondback 360® Coronary Orbital Atherectomy System Micro Crown for Approval in Japan
Mitsubishi Heavy Industries Machine Tool Completes Delivery of 1st ABLASER Laser Micromachining System to Leading Domestic Manufacturer of Precision Instruments
æ¬§ç›Ÿå§”å‘˜ä¼šæ ¸å‡†æ¦ç”°çš„ADCETRIS® (brentuximab vedotin)用于移æ¤åŽéœå¥‡é‡‘淋巴瘤巩固治疗
美国绿色建ç‘委员会首å¸æ‰§è¡Œå®˜Rick Fedrizzi被任命为国际WELL建ç‘ç ”ç©¶æ‰€è‘£äº‹é•¿å…¼é¦–å¸æ‰§è¡Œå®˜
One of the World’s Leading Centers for Cardiovascular Medicine & Transplantation Adopts Masimo’s SedLine® Brain Function Monitoring and O3™ Regional Oximetry
Study Sheds New Light On ‘Global Citizens’ And How They Spend Money Outside Their Home Countries
{{#tags}}- {{label}}
{{/tags}}